https://www.prnewswire.com/news-releases/triastek-receives-fda-ind-clearance-for-3d-printed-medicine-for-the-treatment-of-ulcerative-colitis-301682686.html
Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
/PRNewswire/ -- Triastek, Inc. ("Triastek") a global healthcare company pioneering 3D printing of pharmaceuticals with its proprietary technology, Melt...
https://3dprintingindustry.com/news/triastek-receives-fda-ind-clearance-for-3d-printed-drug-to-treat-rheumatoid-arthritis-184159/
Triastek receives FDA IND clearance for 3D printed drug to treat rheumatoid arthritis - 3D Printing...
Feb 10, 2021 - Triastek has received IND clearance from the FDA for its first 3D printed drug product, T19, designed to treat rheumatoid arthritis.